PMC7522181_01
PMC7522181_02
PMC7522181_03
Percentage of CNS, PNS, and neurovascular complications observed in the COVID-19 patients
42399_2020_527_Fig3_HTML.jpg
PMC7522181_03_42399_2020_527_Fig3_HTML.jpg
Fig3
Fisher syndrome. Figure 3 depicts the neurological manifestations affecting the CNS and PNS of 630 confirmed SARS- CoV-2 cases from a chronological review of 41 articles. Figure 3 represents data obtained from this chronological review of 41 articles of 630 confirmed COVID-19 patients with neurological complications from February to May 2020, and reported here on July 1, 2020.
PMC7522181_04
PMC7522181_05
PMC7522181_06
PMC7522181_07
Summary of the neurological complications reported in COVID-19 patients
42399_2020_527_Fig4_HTML.jpg
PMC7522181_07_42399_2020_527_Fig4_HTML.jpg
Fig4
Figure 4 depicts all the neurologic complications reported with COVID-19 patients.